ATLN · NASDAQ · Medical - Pharmaceuticals

Atlantic International (ATLN)

North American staffing and European IT talent services.

$0.9001
vs last close0.00 (0.00%)
No recent trading data

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue98116101105108130103103110120250320
Cost of revenue86104909396116929198109228296
Gross profit121310111213111112112124
121512201819212021343635
101610191718191920333235
Selling & marketing010000000000
General & administrative0150000000000
Other expenses2−11111111140
Operating income0−2−1−8−7−6−9−9−9−23−15−15
−5−5−5−64−2−38−1−2−2−4−16−72
Interest expense000412122444
Other non-operating income−135600360000120
Income before tax−5−8−6−72−8−44−11−11−11−27−31−88
Income tax expense−1−2−1−17−12500000−1
Net income from continuing operations−4−5−5−55−7−69−11−11−11−27−31−86
Net income−4−5−5−55−7−69−11−11−11−27−31−86
EPS, basic−$0.05−$0.05−$0.04−$1.96−$0.16−$1.29−$0.20−$0.20−$0.20−$0.48−$0.44−$0.98
EPS, diluted−$0.05−$0.05−$0.04−$1.96−$0.16−$1.29−$0.20−$0.20−$0.20−$0.48−$0.44−$0.98
Weighted average shares, basic252525284553545555557481
Weighted average shares, diluted252525284553545555557481
EBITDA2−4−5−67−6−41−8−7−7−22−22−76
Depreciation & amortization111111222254
EBIT0−5−6−68−7−42−9−9−9−23−270